Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Director Stephanie Okey Sells 17,500 SharesTicker Report • about 1 month agoCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX - Get Free Report) Director Stephanie Okey sold 17,500 shares of Crinetics Pharmaceuticals stock in a transaction dated Thursday, March 28th. The shares...